MiR-137 inhibits cervical cancer progression via down-modulating Notch1 and inhibiting the PI3K/AKT/mTOR signaling pathway

BACKGROUND: Cervical cancer (CC) is frequently diagnosed, and accounts for a large proportion of cancer-related mortality worldwide. Therefore, it is an urgent need to explore the mechanisms of CC progression and seek new therapeutic targets. We know that microRNA-137 (miR-137) is involved in CC pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Gui, Ying, Wang, Lina, Huang, Zhihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799131/
https://www.ncbi.nlm.nih.gov/pubmed/35116675
http://dx.doi.org/10.21037/tcr-21-1049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799131/
https://www.ncbi.nlm.nih.gov/pubmed/35116675
http://dx.doi.org/10.21037/tcr-21-1049

Ejemplares similares